Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Interferon Sciences explores cancer indications for Alferon N Injection

Jan. 16, 2002

High-dose HspE7 effective and well tolerated in high-grade anal dysplasia

Jan. 14, 2002

Interim analysis of first phase III Provenge trial inconclusive

Jan. 14, 2002

Ceplene plus IL-2 prolongs survival in subset of metastatic melanoma patients

Jan. 14, 2002

Medarex's tumor vaccine program to evaluate melanoma vaccines in conjunction with MDX-010

Jan. 11, 2002

Transgene's Ad-IFNgamma product candidate enters phase I trial for cutaneous lymphoma

Jan. 11, 2002

CD40-targeted MAb moves to clinical development at Genentech

Jan. 10, 2002

HGS and CAT form TRAIL-R1 antibody partnership

Jan. 10, 2002

Abgenix submits IND for ABX-MA1 in metastatic melanoma

Jan. 9, 2002

FDA approves IND for Albuleukin to enter clinical trials in treatment of cancer

Jan. 8, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026